Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of recombinant FSH dosing following corifollitropin alfa in patients undergoing IVF/ICSI in a GnRH antagonist protocol
2024-517312-30-00Phase 4Authorised
- Sponsor
- UZ Brussel
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of follitropin beta and corifollitropin alfa in female infertility (3 arms), sponsored by UZ Brussel. Primary endpoint: Mean serum progesterone level on trigger day. Planned start Jun 2019; status: authorised.
02
Drugs
follitropin betacorifollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on 2024-517312-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517312-30-00.